Hiroshi Yamasaki
#159,936
Most Influential Person Now
Hiroshi Yamasaki's AcademicInfluence.com Rankings
Hiroshi Yamasakibiology Degrees
Biology
#12578
World Rank
#16063
Historical Rank
Cell Biology
#676
World Rank
#690
Historical Rank
Genetics
#1383
World Rank
#1485
Historical Rank
Molecular Biology
#2058
World Rank
#2090
Historical Rank
Download Badge
Biology
Hiroshi Yamasaki's Degrees
- PhD Molecular Biology University of Tokyo
- Masters Biochemistry Kyoto University
- Bachelors Biology University of Tokyo
Similar Degrees You Can Earn
Why Is Hiroshi Yamasaki Influential?
(Suggest an Edit or Addition)Hiroshi Yamasaki's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Role of connexin genes in growth control. (1996) (477)
- Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. (1996) (453)
- Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. (1999) (423)
- Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E- cadherin (1991) (378)
- Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. (2000) (356)
- UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. (1994) (317)
- Gap junctional intercellular communication and carcinogenesis. (1990) (274)
- Negative growth control of HeLa cells by connexin genes: connexin species specificity. (1995) (270)
- Gap junctional communication and carcinogenesis (1990) (217)
- Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. (2006) (188)
- Altered homologous and heterologous gap‐junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32 (2007) (179)
- A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. (2000) (177)
- Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. (1996) (170)
- Role of connexin (gap junction) genes in cell growth control and carcinogenesis. (1999) (160)
- Intercellular communication and carcinogenesis. (1995) (158)
- Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. (1994) (156)
- Altered gap junctional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43 (1997) (147)
- Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. (1995) (137)
- Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture. (1981) (120)
- Nuclear localization of β‐catenin in normal and carcinogenic endometrium (1999) (120)
- Cell Transformation Assays as Predictors of Human Carcinogenicity (1999) (114)
- Lack of intercellular communication between chemically transformed and surrounding nontransformed BALB/c 3T3 cells. (1984) (109)
- Inhibition of cell communication between Balb/c 3t3 cells by tumor promoters and protection by cAMP (1984) (107)
- Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells. (1987) (107)
- Evidence for UV-associated activation of telomerase in human skin. (1997) (102)
- Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild‐type connexin43 in a dominant‐negative manner (1998) (98)
- UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. (1998) (98)
- Cell contact but not junctional communication (dye coupling) with biliary epithelial cells is required for hepatocytes to maintain differentiated functions. (1987) (98)
- Cell‐cell communication and growth control of normal and cancer cells: Evidence and hypothesis (1993) (94)
- Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32. (2001) (88)
- Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide (2012) (86)
- Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. (2004) (85)
- Molecular mechanisms of TPA‐mediated inhibition of Gap‐junctional intercellular communication: Evidence for action on the assembly or function but not the expression of connexin 43 in rat liver epithelial cells (1991) (83)
- Gap-junctional intercellular communication in epidermal cell lines from selected stages of SENCAR mouse skin carcinogenesis. (1989) (82)
- Phorbol ester-mediated inhibition of intercellular communication in BALB/c 3T3 cells: relationship to enhancement of cell transformation. (1985) (81)
- Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes (1997) (81)
- Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. (1988) (78)
- Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. (1996) (77)
- Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: Increased expression of cardiac‐type gap junction gene connexin 43 (1990) (76)
- Transgeneration transmission of carcinogenic risk. (1992) (75)
- Aberrant expression and function of gap junctions during carcinogenesis. (1991) (74)
- Changes in gap junction protein (connexin 32) gene expression during rat liver carcinogenesis (1989) (73)
- Hypermethylation in promoter region of E‐cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma (2003) (73)
- Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. (2000) (73)
- Rapid inhibition of intercellular communication between BALB/c 3T3 cells by diacylglycerol, a possible endogenous functional analogue of phorbol esters. (1985) (73)
- Inhibition of gap junctional intercellular communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT. (1994) (73)
- G→A mutations in p53 and Ha‐ras genes in esophageal papillomas induced by N‐nitrosomethylbenzylamine in two strains of rats (1994) (68)
- Control of intracellular movement of connexins by E-cadherin in murine skin papilloma cells. (2001) (65)
- Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project. (1996) (62)
- Specific viral oncogenes cause differential effects on cell‐to‐cell communication, relevant to the suppression of the transformed phenotype by normal cells (1988) (62)
- Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. (2003) (61)
- Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis. (1999) (60)
- Phenobarbital specifically reduces gap junction protein mRNA level in rat liver (1988) (58)
- A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. (1997) (57)
- Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice. (2001) (56)
- Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line (2005) (56)
- Intercellular communication of transformed and non-transformed rat liver epithelial cells. Modulation by TPA. (1986) (55)
- Inhibition of intrinsic gap‐junction intercellular communication and enhancement of tumorigenicity of the rat bladder carcinoma cell line BC31 by a dominant‐negative connexin 43 mutant (1998) (55)
- Patched (ptch)-associated preferential expression of smoothened (smoh) in human basal cell carcinoma of the skin. (1997) (54)
- Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails. (1999) (52)
- Connexins in tumour suppression and cancer therapy. (1999) (52)
- Tumour promoter-mediated reversible inhibition of cell-cell communication (electrical coupling). Relationship with phorbol ester binding and de novo macromolecule synthesis. (1983) (51)
- Tumor promotion: models and assay systems. (1990) (51)
- Non-genotoxic mechanisms of carcinogenesis: studies of cell transformation and gap junctional intercellular communication. (1995) (51)
- Induction of cell transformation by mutated 16K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells (1998) (50)
- p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia. (1995) (50)
- Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro. (1990) (48)
- Inhibition of junctional intercellular communication as a possible short-term test to detect tumor-promoting agents: results with nine chemicals tested by dye transfer assay in Chinese hamster V79 cells. (1986) (48)
- Suppressed gap junctional intercellular communication in carcinogenesis of endometrium (2001) (47)
- Performance of tests for cell transformation and gap-junction intercellular communication for detecting nongenotoxic carcinogenic activity. (1992) (47)
- Selective gap-junctional communication capacity of transformed and non-transformed rat liver epithelial cell lines. (1988) (46)
- Expression and function of connexin in normal and transformed human keratinocytes in culture. (1994) (46)
- Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation. (1988) (44)
- Cx32 gene mutation in a chemically induced rat liver tumour. (1996) (44)
- Reduced gap junctional intercellular communication and altered biological effects in mouse osteoblast and rat liver oval cell lines transfected with dominant‐negative connexin 43 (2003) (42)
- Identification of two transcripts of AMLI/ETO‐fused gene in t(8;21) leukemic cells and expression of wild‐type ETO gene in hematopoietic cells (1995) (42)
- Tissue‐specific activating mutations of Ha‐ and Ki‐ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA (1990) (41)
- Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients. (1997) (41)
- High frequency of ki‐ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus (1995) (41)
- Negative growth control of renal cell carcinoma cell by connexin 32: Possible involvement of Her‐2 (2004) (40)
- Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients. (2004) (40)
- Suppression of gap junctional intercellular communication via 5' CpG island methylation in promoter region of E-cadherin gene in endometrial cancer cells. (2003) (39)
- Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression (1998) (38)
- Intercellular communication capacity as a possible determinant of transformation sensitivity of BALB/c 3T3 clonal cells. (1985) (37)
- Perinatal and multigenerational effect of carcinogens: possible contribution to determination of cancer susceptibility. (1992) (37)
- Possible molecular mechanism of loss of homologous and heterologous gap junctional intercellular communication in rat liver epithelial cell lines. (1994) (37)
- Down-Regulation of Connexin 32 Gene Expression through DNA Methylation in a Human Renal Cell Carcinoma Cell (2003) (36)
- Transplacental induction of a specific mutation in fetal Ha‐ras and its critical role in post‐natal carcinogenesis (1987) (36)
- Novel method for selective killing of transformed rodent cells through intercellular communication, with possible therapeutic applications. (1988) (34)
- Regulation of cellular invasion and matrix metalloproteinase activity in HepG2 cell by connexin 26 transfection (2001) (34)
- Detection of non-genotoxic carcinogens in the BALB/c 3T3 cell transformation/mutation assay system. (1989) (33)
- Relationship between chemically induced ha‐ras mutation and transformation of BALB/c 3T3 cells: Evidence for chemical‐specific activation and cell type—specific recruitment of oncogene in transformation (2006) (33)
- Effects on intercellular communication in human keratinocytes and liver-derived cells of polychlorinated biphenyl congeners with differing in vivo promotion activities. (1990) (32)
- An improved long-term culture of rat hepatocytes to detect liver tumour-promoting agents: results with phenobarbital. (1993) (31)
- Assignment of connexin 26 (GJB2) and 46 (GJA3) genes to human chromosome 13q11-->q12 and mouse chromosome 14D1-E1 by in situ hybridization. (1996) (31)
- In vitro and in vivo effects of retrovirus-mediated transfer of the connexin 43 gene in malignant gliomas: consequences for HSVtk/GCV anticancer gene therapy (1998) (30)
- Role of blocked gap junctional intercellular communication in non-genotoxic carcinogenesis. (1995) (30)
- Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. (1997) (29)
- High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia. (1995) (29)
- Genetic control of the regulation of cell susceptibility to carcinogenic polycyclic hydrocarbons by cyclic AMP (1974) (28)
- Allele‐specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis (1996) (28)
- An update on minding the gap in cancer. (2018) (28)
- Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase/ganciclovir gene therapy (1998) (28)
- Human connexin 37 is polymorphic but not mutated in tumours. (1996) (28)
- A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells. (2004) (28)
- Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication. (1996) (28)
- Connexin 32 potentiates vinblastine‐induced cytotoxicity in renal cell carcinoma cells (2007) (28)
- Co‐ordinated expression of connexins 26 and 32 in human endometrial glandular epithelium during the reproductive cycle and the influence of hormone replacement therapy (1997) (27)
- Specific binding of phorbol esters to Friend erythroleukemia cells--general properties, down regulation and relationship to cell differentiation. (1982) (27)
- The expression of the tumor suppressor gene connexin 26 is not mediated by methylation in human esophageal cancer cells (2003) (26)
- Tumor-suppressive effect of connexin 32 in renal cell carcinoma from maintenance hemodialysis patients. (2003) (26)
- Independent regulation of two types of aryl hydrocarbon (benzo(a)pyrene) hydroxylase in mammalian cells (1976) (25)
- Inhibition of intercellular communication and enhancement of morphological transformation of Syrian hamster embryo cells by TPA. Use of TPA-sensitive and TPA-resistant cell lines. (1985) (25)
- Overexpression of estrogen receptor-α gene suppresses gap junctional intercellular communication in endometrial carcinoma cells (2004) (24)
- Stimulation of intercellular communication of poor‐communicating cells by gap‐junction‐competent cells enhances the HSV‐TK/GCV bystander effect in vitro (2001) (24)
- Role of the Cytoplasmic Loop Domain of Cx43 in Its Intracellular Localization and Function: Possible Interaction with Cadherin (2007) (24)
- Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells. (1993) (23)
- Induction of a bystander effect in HeLa cells by using a bigenic vector carrying viral thymidine kinase and connexin32 genes (2001) (23)
- Connexin 32 as an anti-invasive and anti-metastatic gene in renal cell carcinoma. (2006) (22)
- Identification and quantification of a carcinogen-induced molecular initiation event in cell transformation. (1992) (22)
- Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data. (1997) (22)
- Protective effect of cAMP on tumor promoter-mediated inhibition of cell-cell communication. (1984) (22)
- Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation. (1984) (22)
- Myelomonoblastic leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c‐KIT+ immature cells (1997) (22)
- Human hemangiosarcomas have a common polymorphism but no mutations in the connexin37 gene (2000) (21)
- Microsatellite alterations in human and rat esophageal tumors at selective loci (1995) (20)
- Interaction and distinction of genotoxic and non-genotoxic events in carcinogenesis. (1992) (20)
- Altered expression of connexins in urethane-induced mouse lung adenomas. (2006) (20)
- Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects. (1998) (20)
- Transplacental and transgeneration carcinogenic effect of 7,12-dimethylbenz[a]anthracene: relationship with ras oncogene activation. (1992) (20)
- Aberrant expression, function and localization of connexins in human esophageal carcinoma cell lines with different degrees of tumorigenicity (2005) (19)
- Role of cell-cell communication in tumor suppression. (1990) (19)
- A novel sensitive method to detect frameshift mutations in exonic repeat sequences of cancer-related genes. (1999) (19)
- Genomic instability in multistage carcinogenesis. (2000) (19)
- Reduced expression of the P2 form of the gap junction protein connexin43 in malignant meningiomas. (1997) (19)
- Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus (1995) (19)
- Genomic instability in oral squamous cell carcinoma: relationship to betel-quid chewing. (2004) (18)
- Control of Intracellular Localization and Function of Cx43 by SEMA3F (2007) (18)
- The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma (2008) (18)
- Intercellular communication, cell differentiation and tumour promotion. (1984) (18)
- Metsovo-tremolite asbestos fibres: in vitro effects on mutation, chromosome aberration, cell transformation and intercellular communication. (1992) (18)
- Classical cadherins in urological cancers. (2000) (18)
- Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted. (2000) (17)
- Connexin genes and cell growth control. (1996) (17)
- Enhancement of transformation and continuous inhibition of intercellular communication by 1-oleoyl-2-acetyl glycerol in BALB/c 3T3 cells. (1987) (17)
- Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia. (2010) (17)
- Role of intercellular communication in BALB/c 3T3 cell transformation. (1985) (16)
- Tumor promoters specifically and reversibly disturb development and behavior of Caenorhabditis elegans (2004) (15)
- Increased genetic stability of HeLa cells after connexin 43 gene transfection. (1997) (15)
- Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. (1995) (15)
- Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation. (1996) (15)
- Gap-junctional communication alterations at various regulatory levels of connexin expression and function during animal and human carcinogenesis (1993) (14)
- Role of intercellular communication in the control of critical gene expression during multistage carcinogenesis. (1988) (14)
- Expression of AML1 and ETO Transcripts in hematopoietic cells. (1995) (14)
- Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells. (1995) (14)
- Inhibition of the formation of electrical cell coupling of FL cell by tumor promoters. (1981) (13)
- Bystander effect from cytosine deaminase and uracil phosphoribosyl transferase genes in vitro: a partial contribution of gap junctions. (2009) (13)
- L-myc allele polymorphism and prognosis for metastases in Russian gastric cancer patients. (1994) (13)
- Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia. (1997) (13)
- Association of viral oncogene-induced changes in gap junctional intercellular communication and morphological transformation in BALB/c3T3 cells. (1993) (13)
- Growth control of 3T3 fibroblast cell lines established from connexin 43–deficient mice (1998) (13)
- Possible role of activated ras genes in human esophageal carcinogenesis (1993) (13)
- Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells. (2006) (13)
- Metabolism of the carcinogenic hydrocarbon benzo(a)pyrene in human fibroblast and epithelial cells. II. Differences in metabolism to water‐soluble products and aryl hydrocarbon hydroxylase activity (1977) (13)
- Cell-Cell Interaction and Carcinogenesis (1986) (12)
- Reversible inhibition of cell differentiation by phorbol esters as a possible mechanism of the promotion step in chemical carcinogenesis. (1980) (12)
- Lack of Correlation between the Gap Junctional Communication Capacity of Human Colon Cancer Cell Lines and Expression of the DCC Gene, a Homologue of a Cell Adhesion Molecule (N‐CAM) (1993) (11)
- TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation. (1997) (11)
- CC to TT mutation in the mitochondrial DNA of normal skin: relationship to ultraviolet light exposure. (2000) (11)
- Long‐term remission in an elderly patient with mantle cell leukemia treated with low‐dose cyclophosphamide (2000) (11)
- Effects of sodium L-ascorbate, uracil, butylated hydroxyanisole and extracellular pH on junctional intercellular communication of BALB/c 3T3 cells. (1988) (10)
- Gap junction intercellular communication propagates cell death in cancerous cells (2002) (10)
- Multistage carcinogenesis: implications for risk estimation (1988) (10)
- A human T-cell lymphotropic virus type-I carrier with chronic renal failure, aplastic anemia, myelopathy, uveitis, Sjögren's syndrome and panniculitis. (1996) (10)
- Transformation assay of established cell lines: mechanisms and application. Proceedings of a workshop organized by IARC in collaboration with the US National Cancer Institute and the US Environmental Protection Agency. Lyon, 15-17 February 1984. (1985) (10)
- Comparative effects of a complete tumor promoter, TPA, and a second-stage tumor promoter, RPA, on intercellular communication, cell differentiation and cell transformation. (1985) (9)
- Response of cultured rat liver epithelial cell lines to tumour-promoting phorbol esters. (1985) (9)
- Use of the Syrian hamster embryo (SHE) cell transformation assay for predicting the carcinogenic potential of chemicals. Introduction. (1996) (9)
- Tumor promotion--mechanisms and implication to risk estimation. (2009) (9)
- Ex-vivo dye transfer assay as an approach to study gap junctional intercellular communication disorders in hepatocarcinogenesis (1995) (9)
- Regulation of gap-junctional intercellular communication in transformation-sensitive and transformation-resistant BALB/c 3T3 cell variants. (1991) (9)
- Dose and frequency effect in mouse skin tumor promotion. (1989) (9)
- Application of Fluorescence Resonance Energy Transfer (FRET) to Investigation of Light‐Induced Conformational Changes of the Phoborhodopsin/Transducer Complex † (2007) (9)
- Gap junctional intercellular communication and connexin expression in normal and SV 40-transformed human liver cells in vitro. (1993) (9)
- Long-term effect of a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, on induced differentiation of Friend leukemia cells. (1980) (9)
- Dynamics of light-induced conformational changes of the phoborhodopsin/transducer complex formed in the n-dodecyl beta-D-maltoside micelle. (2007) (9)
- Characterization of a human placental factor which inhibits specific binding of phorbol esters to cultured cells. (1984) (8)
- CHROMOSOMAL DAMAGE AND GAP JUNCTIONAL INTERCELLULAR COMMUNICATION IN MESOTHELIOMA CELL LINES AND CULTURED HUMAN PRIMARY MESOTHELIAL CELLS TREATED WITH MMMF (1991) (8)
- Cellular and molecular methods to study the role of gap junctional intercellular communication in toxicology. (1997) (8)
- Inhibitory effect of tumor promoting phorbol esters and mezerein on human mixed lymphocyte reaction. (1981) (8)
- Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene. (2005) (8)
- Inhibition of Balb/c 3T3 cell transformation by synthetic acyclic retinoid NIK-333; possible involvement of enhanced gap junctional intercellular communication. (2007) (8)
- Growth suppression of transformed BALB/c 3T3 cells by transforming growth factor beta 1 occurs only in the presence of their normal counterparts. (1994) (7)
- Tumor Promoter-Mediated Modulation of Cell Differentiation and Communication: The Phorbol Ester — Oncogene Connection (1987) (7)
- Connexin 43 Suppresses MFG-E 8 While Inducing Contact Growth Inhibition of Glioma Cells 1 (2000) (6)
- Frequency of HPRT gene mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines. (1998) (6)
- Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects. (1988) (6)
- Short-term assays to predict carcinogenicity. In-vitro assays that may be predictive of tumour-promoting agents. (1986) (6)
- Membrane interaction and modulation of gene expression by tumor promoters. (1983) (6)
- Aberrant control of connexin expression and functions in multistage rat and human hepatocarcinogenesis (1995) (6)
- Changes of gap junctional intercellular communication during multistage carcinogenesis. (1990) (5)
- Acute myelomonoblastic leukemia carrying the PEBP2beta/MYH11 fusion gene. (1998) (5)
- Connexin 37 gene is not mutated in lung carcinomas 3LL and CMT. (2003) (5)
- Malignant transformation of simian virus 40–immortalized human milk epithelial cells by chemical carcinogenesis accompanied by loss of heterozygosity on chromosome 1 but not microsatellite instability (1998) (5)
- Short-term assays to detect tumor-promoting activity of environmental chemicals. (1989) (5)
- Mutagenicity, sister chromatid exchange inducibility andin vitro cell transforming ability of particulates from Athens air (1987) (5)
- In vitro approaches to identify tumour-promoting agents: cell transformation and intercellular communication. (1984) (5)
- Cell-to-cell communication in cultured rat thyroid monolayer cells is inhibited dose-dependently by methimazole. (1992) (4)
- Bystander effect in suicide gene therapy of cancers (1999) (4)
- In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation. (1982) (4)
- 1-Oleoyl 2-acetyl glycerol inhibits differentiation of TPA-sensitive but not of TPA-resistant Friend cells. (1986) (4)
- Epigenetic inactivation of connexin 32 in renal cell carcinoma from hemodialytic patients. (2004) (4)
- Use of data from short-term tests in the evaluation of the carcinogenicity of environmental chemicals to humans. (1982) (4)
- Transformation in cell culture. (1980) (3)
- NBT-II carcinoma behaviour is not dependent on cell-cell communication through gap junctions. (2002) (3)
- Influence on cell-cell communication (dye-transfer) of the oncogenic beta-blocker DL-ZAMI 1305: possible relation to tumor promotion. (1985) (3)
- Short-term assays to predict carcinogenicity. Mammalian cell transformation in culture. (1986) (3)
- Growth suppression of transformed cells by a human placental extract not related to transforming growth factor Β (2005) (3)
- Use of primary keratinocyte cultures from plucked human hairs for analysis of gap junctional intercellular communication. (1991) (3)
- Growth inhibition by expression of connexin 26 in HeLa cells (1995) (2)
- Risk Assessment Committee:; Comparative Survey of Food Safety Commission of Japan (FSCJ) with Oversea Organizations (2013) (2)
- A phorbol ester-binding inhibitory factor from human placenta. Partial purification, characterization and biological effects. (1984) (2)
- The role of inhibited gap junction function in carcinogenesis (1990) (2)
- Tumour-promoting phorbol esters rapidly inhibit bud formation in hydra (1987) (2)
- [Role of junctional intercellular communication in hepatic carcinogenesis in rats]. (1990) (2)
- Growth of only highly tumorigenic cell lines is inhibited by EAP, a human placental fraction. (1993) (2)
- Cellular mechanisms of in-vitro cell transformation: role of blocked intercellular communication. (1986) (1)
- Modulation of cellular phorbol ester binding and/or protein kinase C activity by human placental fractions. (1988) (1)
- Cell communication and morphological transformation in Syrian hamster embryo cells (1995) (1)
- Role of oncogene activation during prenatal (transplacental) initiation and postnatal promotion of mouse skin tumours. (1989) (1)
- CD4+ CD8+ granular lymphocytic leukemia arising in a patient with acute myeloblastic leukemia. (1994) (1)
- Understanding Multi-Stage Carcinogenesis at the Molecular Level: Notes on Recent Progress (1989) (1)
- Possible Role of Selective Gap Junctional Intercellular Communication in Multistage Carcinogenesis (1)
- [Tumor promotion in chemical carcinogenesis-inhibition of cell differentiation by phorbol esters (author's transl)]. (1979) (1)
- ROLE OF ONCOGENES AND INTERCELLULAR COMMUNICATION (1990) (0)
- Dose and FrequencyEffect in Mouse Skin TumorPromotion (1989) (0)
- Roles of connexin (gap junction) genes in tumour suppression and cancer gene therapy (1995) (0)
- Tumour promoting activity of TGF β (1987) (0)
- Transforming Growth Factor ßas a Potent Promoter in Two-Stage BALB/c 3T3 Cell Transformation1 (2006) (0)
- Decreased CD138 Expression in Myeloma Cells: A Potential Indicator of Poor Prognosis and Aberrant Differentiation, (2011) (0)
- [Multi-stage carcinogenesis-application to cancer prevention (author's transl)]. (1980) (0)
- 178 Telomerase activity in human skin and skin tumor (1996) (0)
- Estimation of functional state of intercellular communication channels during rat liver carcinogenesis (1990) (0)
- Comparative effects of a complete tumor promoter 12 o tetradecanoylphorbol 13 acetate and a 2nd stage tumor promoter 12 o retinoylphorbol 13 acetate on intercellular communication cell differentiation and cell transformation (1985) (0)
- Gene Associated With Myeloblastic Leukemias AML1/PEBP2?B Biallelic and Heterozygous Point Mutations in the Runt Domain of the (2013) (0)
- Cellular and Molecular Mechanisms of Tumour Promotion and their Implications for Risk Assessment (2007) (0)
- Decreased connexin 32 expression is associated with cellular proliferation and progression of hepatocarcinogenesis in the rat (1995) (0)
- P-24 Detection of the UV-specific mutation(CC to TT)in mitochondrial DNA of human skin by the mutant allele-specific PCR. (1998) (0)
- DNA Repeats and Tumor Suppressor Genes in Human Gastric Cancer I (2007) (0)
- EL-5 Gap-junctional Intercellular Communication and Toxicology. (2001) (0)
- UV-specific P53 tumour suppressor gene mutations in squamous cell carcinoma in renal allograft recipients (1994) (0)
- Tumour promoting phorbol ester-cell interaction (1983) (0)
- [Functional analysis of intercellular communication of tissue and culture cells using tumor promoters]. (1983) (0)
- [Activation of the Ha-ras oncogene in tumors induced in mice by transplacental exposure to 7,12-dimethylbenz(a)anthracene]. (1991) (0)
- The use of short-term test results for human cancer risk assessment (1983) (0)
- Advances in Brief Alterations of ( C A ) n DNA Repeats and Tumor Suppressor Genes in Human Gastric Cancer (2007) (0)
- 2P328 Effect of azide on dynamics of light-induced conformational change of phoborhodopsin/transducer complex(42. Sensory signal transduction,Poster Session,Abstract,Meeting Program of EABS & BSJ 2006) (2006) (0)
- ML-5 GENOMIC INSTABILITY AND ENVIRONMENTAL CARCINOGENESIS (1998) (0)
- To explore the program of cell differentiation in Friend murine eryth roleukemia (MEL) cells, we used three clonal variants: phorbol 12-my (2006) (0)
- [Role of cell-cell interaction in tumor promotion]. (1986) (0)
- Connexins in human endometrium and correlation to carcinogenesis (2006) (0)
- Long-term Effect of a Tumor Promoter , 12-O-Tetradecanoylphorbol-IS-Acetate , on Induced Differentiation of Friend Leukemia Cells 1 (2006) (0)
- Role of activator protein‐1 and methylation function in 12‐o‐tetradecanoylphorbol‐13‐acetate—mediated inhibition of differentiation of friend erythroleukemia cells (1992) (0)
- Molecular and Cellular Mechanisms of Multistage Carcinogenesis; Role of Oncogenes and Intercellular Communication (1990) (0)
- Specific binding and biological effects of tumor promoting phorbol esters on sponges (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hiroshi Yamasaki?
Hiroshi Yamasaki is affiliated with the following schools:
